baber/WOPTO huggingface dataset:
Patent CA-2664127-A1 (CA)
Title: Standby instrument for an aircraft instrument panel detecting overload, in particular during the landing phase
Inventor: COLLOT LIONEL
IPC: G01G19/07
Filed: 2007-09-17
Abstract: The present invention relates to a backup instrument fitted to the instrument panel of an aircraft to detect overload. The backup instrument comprises means for calculating and displaying flight information on the basis of data supplied by associated sensors (41, 42, 43, 45) incorporated into a backup system. It also comprises a module (403) that detects that the aircraft is overloaded on the basis of the data supplied to display the flight information. The invention applies in particular to the detection of overload during heavy landings. More generally, it applies to the detection and display of overloading of an aircraft in various types of environment.
Patent CA-2665508-A1 (CA)
Inventor: BRAEUNINGER SIGMAR
IPC: H01M4/86
Filed: 2007-09-14
Abstract: The invention relates to a membrane-electrode unit comprising at least one membrane, at least two electrode layers, and at least one barrier junction that contains at least one catalytically active species and/or at least one adsorbent material, the barrier junction not being electronically conducting when a catalytically active species is provided. Also disclosed are the use of such a barrier junction in a membrane-electrode unit and in a fuel cell as well as a gas diffusion electrode and a fuel cell containing such a membrane-electrode unit.
Patent CA-2668922-A1 (CA)
Title: Device for treating wounds
Inventor: AICHER MARTIN
IPC: A61F13/00
Filed: 2007-11-09
Abstract: The invention relates to a device for treating wounds of a patient by means of low pressure. Said device comprises a wound dressing and a cover film. Said cover film is placed on the wound dressing and is connected thereto. Said cover film is at least partially folded or rolled together before use. Said device can be easily adapted to the size and shape of the wound and is easy to handle.
Patent CA-2669756-A1 (CA)
Title: Powder formulation for inhalation
Inventor: MUELLER-WALZ RUDI
IPC: A61K9/72
Filed: 2007-11-12
Abstract: A powder formulation for inhalation comprising a macromolecule and a crystalline carrier material.
Patent CA-2670549-A1 (CA)
Inventor: GELONESE GUISEPPE ANTONIO
IPC: H02J3/00
Filed: 2007-11-27
Abstract: The present invention discloses a power supply control device to which can be attached a number of electrical device(s), such as a computer or AV equipment. The power supply device is able to determine and monitor standby power usage levels of the device(s) so that when the control device detects that the connected electrical device(s) are not being used power supply is removed from the device(s).
Patent CA-2676050-A1 (CA)
Title: Parallel graphics rendering systems and methods supporting task-based object division
Inventor: BAKALASH REUVEN
IPC: G06T1/20
Filed: 2009-08-20
Abstract: In a PC-level hosting computing system embodying a parallel graphics processing subsystem (PGPS) having a plurality of GPPLs and supporting at least a task-based object division mode of parallel operation, a method of method of operating the GPPLs its task-based object division mode of operation during the run--time of a graphics based application executing on the CPU(s) of the host computing system, and, within each frame in the scene to be rendered, analyzing the stream of graphics commands and data generated by the graphics application for graphics processing tasks associated the frame. The graphics processing tasks are then distributed among plurality of GPPLs, and each GPPL executes its received graphics processing tasks, by processing the graphics commands and data associated with its distributed graphics processing tasks, and renders partial image components.  The partial image components are ultimately recomposited to produce a complete image for the frame and the complete image is displayed on one or more display screens. In a preferred embodiment, the partial image components are rendered in the GPPLs using a depth-less based method of image rendering.
Patent CA-2677072-A1 (CA)
Title: Method, apparatus and computer program product for handover failure recovery
Inventor: SEBIRE BENOIST
IPC: H04W4/24
Filed: 2008-03-13
Abstract: An apparatus for facilitating handover failure recovery may include a handover management element configured to receive, at a target node, a handover request from a source node regarding the handover of communications with a mobile terminal. The handover request may include identity information indicative of the mobile terminal. The identity information may be the identity information used to identify the mobile terminal to the source node during establishment of the original connection between the source node and the mobile terminal. The handover management element may be further configured to receive a request for a connection from the mobile terminal subsequent to a radio link failure and prior to handover completion. Based on matching the identity information from the request for connection and the identity information received from the source node, the target node may establish communication with the mobile terminal based on access stratum configuration information used by the source node.
Patent CA-2681306-A1 (CA)
Inventor: COHEN YARIV
IPC: C05F7/00
Filed: 2008-01-04
Abstract: Phosphorous ions are extracted (210) from solutions by adsorbing phosphorous ions in a scavenger and by releasing the phosphorous ions into an eluate during regeneration (230) of the scavenger. The regeneration (230) is performed by ammonia. Phosphate anions are precipitated (262) in form of tri-ammonium phosphate upon introduction (260) of excess amounts of ammonia. The ammonia remaining in solution after the precipitation of tri- ammonium phosphate is reused (266) for regenerating the scavenger.
Patent CA-2682525-A1 (CA)
Inventor: KAPEL CHRISTIAN MOLIIN OUTZEN
IPC: A61K35/62
Filed: 2008-03-31
Abstract: The present application describes a novel, advantageous purification method which guarantees the embryonation capability and the viability of a worm egg suspension. The T. suis worm eggs are first treated in a non-embryonated condition in a sulfuric acid solution at about <= ph 2. Bacteria and viruses are thereby killed successfully. The germination number of yeasts and fungi is reduced. In a second step, the pH-value is increased and an orally tolerated preservative is added. Yeasts and fungi are thereby killed successfully. The suspension medium used in the second purification step can then be used as a culture medium for additional production (embryonation) and storage.
Patent CA-2685112-A1 (CA)
Inventor: REID DAVID
IPC: A61K45/06
Filed: 2008-05-21
Abstract: The present invention relates to the use of a Compound of formula (I), preferably 4-[3,5-bis(2-hydroxyphenyI)-[l,2,4]triazol-l-yl]benzoic acid or a pharmaceutically acceptable salt thereof for the preparation of a medicament for use in the treatment of biofilm formation, e.g. of P. aeruginosa, e.g. in cystic fibrosis patients.
Patent CA-2685676-A1 (CA)
Inventor: SEAGRAVES JOHN
IPC: A01K39/02
Filed: 2008-05-01
Abstract: The assemblies of the invention are suitable for mounting to or being an Integral part of, an animal enclosure such that the height of a valve-controlled liquid outlet may be adjusted according to the changing needs of growing animals The adjustable liquid delivery assemblies comprise an elongated rail, a liquid delivery unit having at least one liquid delivery head slideably engaged with the elongated rail, a flexible liquid delivery tube for connecting a liquid delivery head to a liquid source, and a means for securing the liquid delivery unit at a selected position on the elongated rail The liquid delivery system may further comprise a retaining rail A means for securing the liquid delivery unit at a selected position on the elongated rail may comprise a linear series of holes disposed along the length of the rail.
Patent CA-2687028-A1 (CA)
Title: Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
Inventor: KAKKIS EMIL D
IPC: A61P35/00
Filed: 2008-08-15
Abstract: The present invention is directed to phenylalanine ammonia-lyase (PAL) variants produced by prokaryotes, wherein such prokaryotic PAL variant has a greater phenylalanine-converting activity and/or a reduced immunogenicity as compared to a wild- type PAL. The invention provides compositions of prokaryotic PAL and biologically active fragments, mutants, variants or analogs thereof, as well as methods for the production, purification, and use of such compositions for therapeutic purposes, including the treatment of cancer.
Patent CA-2687923-A1 (CA)
Inventor: TROUBOUNIS GEORGE
IPC: B01D21/24
Filed: 2008-04-02
Abstract: A flotation apparatus (10) for the separation of solid particles from a suspension with formation of a fraction lacking in solid particles and a fraction rich in solid particles comprises a tank with an inlet (14) for the suspension, with an outlet (16) for the fraction lacking in solid particles, with an outlet (18) for the fraction rich in solid particles, and with at least one block of slats (20) composed of multiple overlapping slats (22), wherein the at least one block of slats (20) has a rear side oriented toward the tank wall and a front side arranged on the opposite side of the block of slats (20). On the rear side of the at least one block of slats, a plate (26) is arranged which extends over at least a part of the rear side of the block of slats, wherein the plate has a plurality of openings which facilitate the penetration of liquid through the plate. The sum of the areas of the individual openings (38) in the upper region, relative to the vertical axis, of the plate, per square centimeter of the plate, is greater than the sum of the areas of the individual openings in the lower region of the plate, per square centimeter of the plate.
Patent CA-2689408-A1 (CA)
Title: Use of antibodies against the cd52 antigen for the treatment of neurological disorders, particularly transmissible spongiform encephalopathy and alzheimer's disease
Inventor: WEBER OLAF
IPC: A61P25/28
Filed: 2008-06-10
Abstract: The present invention relates to the use of antibodies against the CD52 antigen, specifically monoclonal antibodies, for the production of medicaments for the treatment of diseases of the central nervous system, in particular transmissible spongiform encephalopathies, diseases that are also called prion diseases.
Patent CA-2689410-A1 (CA)
Title: Procede pour transmettre des donnees dans un systeme multi-antenne
Inventor: LEE MOON IL
IPC: H04B7/06
Filed: 2008-06-25
Abstract: L'invention concerne un procédé pour transmettre des données dans un système de communications sans fil, consistant : à recevoir des données de rétroaction sur un canal de données de liaison montante, les données de rétroaction comprenant un indicateur de matrice de précodage (PMI), et la valeur de PMI correspondant à un index de livre de code; à transmettre un schéma de précodage pour des données de liaison descendante sur un canal de commande de liaison descendante, le schéma de précodage étant déterminé comme une diversité de transmission indépendamment du PMI reçu, un accusé de réception indiquant un précodage conformément au PMI reçu et un nouveau PMI indiquant qu'il est utilisé dans les données de précodage de liaison descendante à transmettre; et à transmettre les données de liaison descendante su un canal de données de liaison descendante après application d'un précodage conformément au schéma de précodage déterminé.
Patent CA-2690686-A1 (CA)
Inventor: KIUCHI MASATOSHI
IPC: A61K31/381
Filed: 2008-06-13
Abstract: It is intended to provide a novel amine compound represented by the following general formula (I), a pharmaceutically acceptable acid addition salt thereof, a hydrate thereof or a solvate thereof, which has an excellent peripheral blood lymphocyte decreasing action, exhibits excellent immunosuppressive action, antirejection action and the like, and has reduced side effects such as bradycardia. (In the formula, each symbol has the same meaning as in the description.)
Patent CA-2692632-A1 (CA)
Title: Methods and compositions for treatment of cancer and other angiogenesis-related diseases
Inventor: XIE FRANK Y
IPC: A61K48/00
Filed: 2008-07-03
Abstract: The present invention provides nucleic acid molecules that modulate the expression of molecules in the angiopoietin/Tie2 signaling pathway. Methods of using the nucleic acid molecules are also provided.
Patent CA-2694217-A1 (CA)
Inventor: KUWAHARA KOICHI
IPC: A23L17/00
Filed: 2008-07-24
Abstract: To provide a muscular protein denaturation inhibitor which is effective only in a small addition amount because of exerting an excellent effect of inhibiting heat denaturation and freeze denaturation of fish meat-origin muscular proteins, shows almost no taste as a solution, has been approved as a food additive, also has been employed as a component in supplements due to its health-promoting effects, and is safe to the human body. A muscular protein denaturation inhibitor characterized by containing a citric acid salt as the active ingredient and being capable of inhibiting heat denaturation and/or freeze denaturation of fish meat-origin muscular proteins.
Patent CA-2694448-A1 (CA)
Title: Herbicidal composition comprising acetic acid and a natural surfactant
Inventor: MUNGER JAMIE
IPC: A01N25/30
Filed: 2010-02-24
Abstract: The present invention is in respect of a natural herbicide that utilizes acetic acid, i.e. vinegar, to kill weeds. The acetic acid is combined with a natural surfactant, such as yucca extract.
Patent CA-2695161-A1 (CA)
Title: D4 desaturases et d5 elongases
Inventor: BURJA ADAM M
IPC: C12N15/53
Filed: 2007-10-31
Abstract: La présente invention concerne des procédés et des compositions associés à ONC-T18, D4-désaturases, D5 élongases, leur isolement, leur caractérisation, leur production, leur identification, et leur utilisation pour la production d'acides gras, ainsi que des organismes contenant ces compositions et des organismes les exprimant.
Patent CA-2697354-A1 (CA)
Inventor: THOMAS JONATHAN D
IPC: A61L31/06
Filed: 2010-03-22
Abstract: Medical devices having more than one degradation zone or degradation mechanism are used for orthopedic repair devices and soft tissue fixation devices.
Patent CA-2697455-A1 (CA)
Inventor: SALAMITOU PHILIPPE
IPC: E21B49/08
Filed: 2008-06-13
Abstract: An analyzing device to analyze light chemical compounds comprises: - an injector (3) to inject a fluid sample from a flow-line (1) in the analyzing device, - a low pressure chamber (4) comprising a low pressure piston (5), the low pressure chamber (4) receiving the fluid sample from the injector (3), - an analyzing sensor 7 coupled to a plurality of control sensors (8, 9), and receiving the fluid sample from the low pressure chamber (4), - a high pressure chamber (11) comprising a high pressure piston (12), the high pressure chamber (11) receiving the fluid sample from the analyzing sensor (7), and - a controller (14) receiving measurements from the analyzing sensor (7), the control sensor (8, 9) and commanding operations of the injector (3), the low pressure piston (5), and the high pressure piston (12) such that the low pressure piston (5) pushes the fluid sample toward the analyzing sensor (7) in sweeping a determined pressure range encompassing an optimal pressure, the high pressure piston (12) pushes the fluid sample back to the flow line (1) after the fluid sample has been transferred to the high pressure chamber (11).
Patent CA-2708411-A1 (CA)
Inventor: FRANTZ GRETCHEN
IPC: C12Q1/68
Filed: 2002-09-11
Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
Patent CA-2708793-A1 (CA)
Title: Aminothiazoles and their uses
Inventor: BUSHELL SIMON
IPC: A61K31/427
Filed: 2008-12-10
Abstract: The present application describes organic compounds that are useful for the treatment, prevention, and/or amelio-ration of diseases particularly bacterial infections, formula (I), and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, atropisomers or racemates thereof, including the pyridine N-oxide thereof;
Patent CA-2708864-A1 (CA)
Inventor: PONOMARENKO EKATERINA ANATOLYEVNA
IPC: A61F13/15
Filed: 2008-12-03
Abstract: A process is claimed for making a composite sheet (10) useful as topsheet with one or more openings (11) to receive fecal material useful for an absorbent article, said composite sheet (10) comprising a wrinkled, patterned elasticized region (12) that comprises a patterned first sheet (13) and an elastic material (15), said first sheet (13) being patterned with troughs (16), that are typically compacter, i.e. of higher density, prior to attachment to the elastic material (15). The troughs (16) are attached to the elastic material (15). The resulting composite sheet (10) has a uniform wrinkle pattern. Also claimed are specific absorbent articles. Also claimed are composite sheets (10) with a specific residual strain and peel force value.
Patent CA-2709771-A1 (CA)
Inventor: BAKER KEVIN P
IPC: C12N15/12
Filed: 2001-06-20
Abstract: Compositions and methods are disclosed for stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more of these uses. Disorders that can be diagnosed, prevented, or treated by the compositions herein include trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy.In addition, the present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Patent CA-2709963-A1 (CA)
Inventor: PAVONE DOMENICO
IPC: C10K1/02
Filed: 2008-12-22
Abstract: The invention relates to a process for the production of synthesis gas by gasification with the aid of air or oxygen or oxygen-saturated air as well as water vapour, a solid or liquid carbon-bearing fuel material being fed to a reactor, in which the fuel material is converted with the aid of air or oxygen or oxygen-saturated air and water vapour at an elevated temperature into a synthesis gas essentially consisting of hydrogen, carbon dioxide and carbon monoxide; the reaction also yields mineral slag droplets which are removed from the reactor separately from the synthesis gas obtained, and the said synthesis gas being discharged from the reactor in any random direction desired; the vaporous alkalies contained in the synthesis gas come into contact with a getter ceramic material so that they separate from the synthesis gas and hence, the synthesis gas can be sent to a slag separation device without previous cooling step and the slag droplets being withdrawn from the said device as liquid slag.
Patent CA-2711037-A1 (CA)
Title: Fluoroalkyl alcohol mixture and method for producing the same
Inventor: MURATA SEIICHIRO
IPC: C09K23/38
Filed: 2009-01-20
Abstract: Disclosed is a mixture of fluoroalkyl alcohols represented by the general formulae: CF3(CF2)n(CH=CF)a(CF2CF2)b(CH2CH2)c OH [la] and CF3(CF2)n-1(CF=CH)a CF2(CF2CF2)b(CH2CH2)c OH [Ib], wherein n is an integer of 1 to 5, a is an integer of 1 to 4, b is an integer of 0 to 3, and c is an integer of 1 to 3. This fluoroalkyl alcohol mixture is produced by the reaction of a fluoroalkyl iodide represented by the general formula: CF3(CF2)n(CH2CF2)a(CF2CF2)b(CH2CH2)c I [II], with N-methylformamide, followed by hydrolysis in the presence of a basic compound.
Patent CA-2711289-A1 (CA)
Inventor: KOYAMA TAKAHUMI
IPC: C12N15/09
Filed: 2008-11-26
Abstract: It is intended to provide a means of highly producing oxalate decarboxylase originating in a microorganism. A  recombinant expression plasmid vector, which contains .alpha.-amylase promoter of a microorganism belonging to the strain Bacillus and an oxalate decarboxylase gene originating in a microorganism that is provided under the control of the promoter, is constructed.  A host bacterium is transformed by this vector to give an oxalate decarboxylase-producing bacterium. A recombinant oxalate decarboxylase is produced by culturing the producing bacterium as described above and then harvesting the oxalate decarboxylase thus produced.
Patent CA-2712312-A1 (CA)
Inventor: TERRA EDSON MARIO SALAMONI
IPC: B65F1/14
Filed: 2009-01-29
Abstract: Stationary compacting, bagging machine comprising a structure intended to compact sorted or unsorted waste inside bags manufactured in laminated polypropylene adequate for this purpose, in which said equipment can perform high compaction of waste, extracting the liquid arising from compaction and eliminating empty spaces between the different kinds of materials, in such a manner that these bags can be deposited in proper landfills with no leaks into the atmosphere nor contamination of the groundwater.
Patent CA-2715315-A1 (CA)
Title: Customised surgical apparatus
Inventor: ASHBY ALAN
IPC: A61B17/17
Filed: 2009-02-26
Abstract: A method for producing a customised surgical instrument or prosthesis for a specific patient is described. At least-one x-ray image of a body part of the patient is captured. A statistical model having a dense set of'anatomical correspondence points across the model is instan-tiated using image data derived from the at least one x-ray image to gener-ate a patient specific model of the body part having a high accuracy sur-face. Patient specific data from the patient specific model is used to gener-ate a design of the customised^ surgical instrument or prosthesis for use in a surgical procedure to be carried out on the body part. The surgical in-strument or prosthesis is then manufactured using the design. A computer implemented method for generating the patient specific model of the body part is also described.
Patent CA-2718892-A1 (CA)
Inventor: DURAN ADIL
IPC: C07D239/42
Filed: 2009-03-19
Abstract: The present invention relates to a method of making pyrimidines of formula (III), wherein X1, X2, R1 and R2 have the meanings as defined herein.
Patent CA-2719118-A1 (CA)
Inventor: DE PERETTI DANIELLE
IPC: A61P19/00
Filed: 2009-03-20
Abstract: Composés de formule (I) dans laquelle : R1 représente un groupe phényle ou naphthyle, un groupe hétéroaryle ou un groupe hétérocyclique, éventuellement substitués par un ou plusieurs atomes ou groupes; Het représente un groupe hétéroaryle monocyclique comportant de 5 à 6 atomes dont de 1 à 3 hétéroatomes choisis parmi N, O et S; X représente de 1 à 3 substituants identiques ou différents l'un de l'autre choisis parmi un hydrogène, un halogène, (C1-C10)alkyle, (C1-C10)alcoxy, NRaRb, nitro, cyano, le (C1-C10)alkyle pouvant être éventuellement substitué par un ou plusieurs groupes choisis parmi un halogène, (C1-C10)alcoxy, (C1-C10)haloalcoxy, NRaRb ou hydroxyle; R représente en position 3, 5, 7 ou 8 de rimidazo[1,2-a]pyridine de 1 à 4 substituants identiques ou différents l'un de l'autre choisi parmi un hydrogène, un halogène, (C1-C10)alkyle, halo(C1-C10)alkyle, (C1-C10)alcoxy; R2 et R3 représentent, indépendamment l'un de l'autre, un atome d'hydrogène,un groupe (C1-C10)alkyle, éventuellement substitué par un groupe Rf, oui un groupe aryle, éventuellement substitué; R4 représente un atome d'hydrogène,un groupe (C1-C10)alkyle, éventuellement substitué par un groupe Rf; un groupe aryle, éventuellement substitué, à l'état de base ou de sel d'addition à un acide. Utilisation en thérapeutique et procédé de synthèse.